IL6 and familial pancreatic carcinoma: In several studies, anti-IL-6 blocking antibodies or sGP130Fc has been demonstrated to inhibit IL-6 signaling and induce apoptosis in breast and pancreatic cancer cells and animal models [28,29,30].